• 

  Weekend Analysis

  A hot VC market gave us Theranos. Today’s bigger boom could bring us more of them.

  January 8, 2022

  Elizabeth Holmes may have been found guilty of fraud, but the moral of the story is less clear.

  Article

  Learn more »
• 

  Weekend Analysis

  Theranos trial puts Silicon Valley investors in the spotlight: Where are they now?

  September 11, 2021

  In federal court, lawyers for the US government have begun pressing fraud charges against Elizabeth Holmes, founder of Theranos. Where are investors in the failed blood-testing startup today?

  Article

  Learn more »
• 

  Venture Capital

  Hot to not: The valuation implosion at Theranos

  May 31, 2018

  For all the success Silicon Valley has enjoyed in this business cycle the ongoing implosion of Theranos is a festering blemish. Here’s a look at how it played out, in real dollars.

  Article

  Learn more »
• 

  Venture Capital

  Ahead of near-certain shutdown, Theranos pleads for cash

  April 10, 2018

  A letter from Elizabeth Holmes to shareholders reveals Theranos will go out of business this summer if existing investors don’t pitch in—and says remaining employees are helping wind it down.

  Article

  Learn more »
• 

  Venture Capital

  Theranos ban a reminder that unicorns aren’t bulletproof

  July 7, 2016

  Regulators recently issued a two-year ban to Theranos CEO Elizabeth Holmes from operating blood-testing facilities, a reminder that unicorns aren’t bulletproof.

  Article

  Learn more »
• 

  Venture Capital

  Can recent Theranos controversy sway investor confidence?

  November 30, 2015

  We take a look into Theranos’ funding and valuation history, as well as some of the controversy that has recently surrounded the company.

  Article

  Learn more »